Home > Insider Trading > Filing (0000950170-24-045153)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1861560	Nuvalent Inc.	NUVL	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1862123	Matthew Shair	C/O Nuvalent, Inc. One Broadway, 14Th Floor Cambridge MA 02142		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Disposition	2024-04-15	25,600	$65.27	1,586,598	No	4	S	Direct
Class A Common Stock	Disposition	2024-04-15	11,900	$66.17	1,574,698	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Class A Common Stock	238,522	Indirect	See Footnote

Footnotes

These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2023.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.77 to $65.76, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) of this Form 4.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.77 to $66.62, inclusive.
These shares are held by Matthew D. Shair 2021 Irrevocable Family Trust. The reporting person has voting and dispositive power over the shares beneficially owned by Matthew D. Shair 2021 Irrevocable Family Trust.